| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brannan Stephen K. serves as a Director at SER. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $3K at current prices.
The biggest single holding is SER (~$3K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | SER Serina Therapeutics, Inc. | Director | Buy | 1,000 | $2.03 | $2,030.00 | New | - | - |